Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions - PubMed (original) (raw)
Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions
S de Waegh et al. J Neurosci. 1990 Jun.
Abstract
The thickness of the myelin sheath in normal myelinated nerve is proportional to the diameter of the axon. In the demyelinating mutant mouse, Trembler, not only is the thickness of the myelin sheath reduced, but the caliber of associated axons is smaller. This correlation suggests that the interaction between axons and Schwann cells may affect the shape and function of axons as well as properties of myelin. Since axonal diameter depends in part on the cytoskeleton and its movement with slow axonal transport, we have compared the properties of slow transport in the sciatic nerve of control and Trembler mice. Studies of the sciatic nerve of normal mice showed that the rates for proteins moving in slow component a (SCa) and slow component b (SCb) are similar to those previously measured in rat. In Trembler mice, tubulin was transported significantly faster than in control mice, with a rate of 1.73 mm/d for Trembler compared to 1.56 mm/d in the control. In contrast, the rate for neurofilament proteins was significantly slower in the Trembler (1.15 mm/d compared to 1.38 mm/d in the control). The majority of proteins in SCb were also transported slower in Trembler than control: actin and calmodulin were transported at 2.29 mm/d as compared to 2.73 mm/d in control, while spectrin and clathrin were transported at 2.01 and 2.43 mm/d, respectively, as compared to 2.54 mm/d in control. The importance of slow axonal transport in regeneration has been suggested by the clear correlation between the rates of regeneration and the rates of SCb. Therefore, we evaluated regeneration of motor axons in Trembler mice to determine whether the regenerative response was affected by deficient Schwann cells. A slower regeneration rate was found in the Trembler (1.7 mm/d) motor axon when compared to the control (2.29 mm/d), but elongation of fibers in regeneration began after a shorter delay in the Trembler (1.6 d) than in control (2.5 d). Thus, deficient Schwann cells and poor myelination appear to affect both quantitative and qualitative properties of slow axonal transport. These changes lead to alterations in the morphological and physiological properties of affected axons.
Similar articles
- Local control of axonal properties by Schwann cells: neurofilaments and axonal transport in homologous and heterologous nerve grafts.
de Waegh SM, Brady ST. de Waegh SM, et al. J Neurosci Res. 1991 Sep;30(1):201-12. doi: 10.1002/jnr.490300121. J Neurosci Res. 1991. PMID: 1795404 - Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells.
Kirkpatrick LL, Brady ST. Kirkpatrick LL, et al. J Neurosci. 1994 Dec;14(12):7440-50. doi: 10.1523/JNEUROSCI.14-12-07440.1994. J Neurosci. 1994. PMID: 7996186 Free PMC article. - Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells.
de Waegh SM, Lee VM, Brady ST. de Waegh SM, et al. Cell. 1992 Feb 7;68(3):451-63. doi: 10.1016/0092-8674(92)90183-d. Cell. 1992. PMID: 1371237 - Organization and slow axonal transport of cytoskeletal proteins under normal and regenerating conditions.
Tashiro T, Komiya Y. Tashiro T, et al. Mol Neurobiol. 1992 Summer-Fall;6(2-3):301-11. doi: 10.1007/BF02780559. Mol Neurobiol. 1992. PMID: 1282336 Review.
Cited by
- Long-term analyses of innervation and neuromuscular integrity in the Trembler-J mouse model of Charcot-Marie-Tooth disease.
Nicks JR, Lee S, Kostamo KA, Harris AB, Sookdeo AM, Notterpek L. Nicks JR, et al. J Neuropathol Exp Neurol. 2013 Oct;72(10):942-54. doi: 10.1097/NEN.0b013e3182a5f96e. J Neuropathol Exp Neurol. 2013. PMID: 24042197 Free PMC article. - Involvement of clathrin light chains in the pathology of Alzheimer's disease.
Nakamura Y, Takeda M, Yoshimi K, Hattori H, Hariguchi S, Kitajima S, Hashimoto S, Nishimura T. Nakamura Y, et al. Acta Neuropathol. 1994;87(1):23-31. doi: 10.1007/BF00386251. Acta Neuropathol. 1994. PMID: 8140893 - AAV1.NT-3 gene therapy for charcot-marie-tooth neuropathy.
Sahenk Z, Galloway G, Clark KR, Malik V, Rodino-Klapac LR, Kaspar BK, Chen L, Braganza C, Montgomery C, Mendell JR. Sahenk Z, et al. Mol Ther. 2014 Mar;22(3):511-521. doi: 10.1038/mt.2013.250. Epub 2013 Oct 28. Mol Ther. 2014. PMID: 24162799 Free PMC article. - Neural and molecular features on Charcot-Marie-Tooth disease plasticity and therapy.
Juárez P, Palau F. Juárez P, et al. Neural Plast. 2012;2012:171636. doi: 10.1155/2012/171636. Epub 2012 Jun 13. Neural Plast. 2012. PMID: 22745917 Free PMC article. Review. - Therapeutic strategies for the inherited neuropathies.
Shy ME. Shy ME. Neuromolecular Med. 2006;8(1-2):255-78. doi: 10.1385/nmm:8:1-2:255. Neuromolecular Med. 2006. PMID: 16775380
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources